Sponsor pipeline

Mabwell (Shanghai) Bioscience Co., Ltd. clinical trial pipeline

Get alerts when Mabwell (Shanghai) Bioscience Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-21 NCT07831863 A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
4
Phase 1/2
8
Phase 2
5
Phase 3
5

Disease areas by active trials

Bladder Cancer (5) · Breast Cancer (3) · Triple-Negative Breast Cancer (3) · COPD (2) · Cervical Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Thalassemia (1)

Get alerts when Mabwell (Shanghai) Bioscience Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free